Overall, these results demonstrate that expression and activity of NNMT are increased in glioblastoma tissue compared to normal brain and that conversion of blood-borne nicotinamide to N1-methylnicotinamide is selectively enhanced by dexamethasone in the tumor. Here, NNMT is linked to glioblastoma.